Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för nepicastat. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

8 träffar

Bibliografisk träff 2015-01-17

Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.

De La Garza R, Bubar MJ, Carbone CL, Moeller FG, Newton TF, Anastasio NC, Harper TA, Ware DL, Fuller MA, Holstein GJ, Jayroe JB, Bandak SI, Reiman KZ, Neale AC, Pickford LB, Cunningham KA.

Prog Neuropsychopharmacol Biol Psychiatry · research-article; randomized controlled trial; journal article · DOI 10.1016/j.pnpbp.2015.01.009

Bibliografisk träff 2014-09-01

The dopamine β-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats.

Colombo G, Maccioni P, Vargiolu D, Loi B, Lobina C, Zaru A, Carai MA, Gessa GL.

Alcohol Clin Exp Res · research support, non-u.s. gov't; journal article · DOI 10.1111/acer.12520

Bibliografisk träff 2013-04-08

The dopamine β-hydroxylase inhibitor, nepicastat, suppresses chocolate self-administration and reinstatement of chocolate seeking in rats.

Zaru A, Maccioni P, Colombo G, Gessa GL.

Br J Nutr · journal article · DOI 10.1017/s0007114513000743

Bibliografisk träff 2013-01-07

The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.

Devoto P, Flore G, Saba P, Bini V, Gessa GL.

Addict Biol · research support, non-u.s. gov't; journal article · DOI 10.1111/adb.12026

Bibliografisk träff 2013-01-03

The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior.

Schroeder JP, Epps SA, Grice TW, Weinshenker D.

Neuropsychopharmacology · research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/npp.2012.267

Bibliografisk träff 2000-10-01

Effects of dopamine beta-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.

Sabbah HN, Stanley WC, Sharov VG, Mishima T, Tanimura M, Benedict CR, Hegde S, Goldstein S.

Circulation · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1161/01.cir.102.16.1990

Bibliografisk träff 1998-06-01

Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor.

Stanley WC, Lee K, Johnson LG, Whiting RL, Eglen RM, Hegde SS.

J Cardiovasc Pharmacol · journal article · DOI 10.1097/00005344-199806000-00023

Bibliografisk träff 1997-08-01

Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.

Stanley WC, Li B, Bonhaus DW, Johnson LG, Lee K, Porter S, Walker K, Martinez G, Eglen RM, Whiting RL, Hegde SS.

Br J Pharmacol · research-article; journal article · DOI 10.1038/sj.bjp.0701315